117 related articles for article (PubMed ID: 8632721)
1. Expression of functional glucagon receptors on lymphoid cells.
Koh WS; Lee M; Yang KH; Kaminski NE
Life Sci; 1996; 58(9):741-51. PubMed ID: 8632721
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2.
Condie R; Herring A; Koh WS; Lee M; Kaminski NE
J Biol Chem; 1996 May; 271(22):13175-83. PubMed ID: 8662742
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism.
Kaminski NE; Koh WS; Yang KH; Lee M; Kessler FK
Biochem Pharmacol; 1994 Nov; 48(10):1899-908. PubMed ID: 7986201
[TBL] [Abstract][Full Text] [Related]
5. Expression and signal transduction of the glucagon receptor in betaTC3 cells.
Li J; Larocca JN; Rodriguez-Gabin AG; Charron MJ
Biochim Biophys Acta; 1997 Apr; 1356(2):229-36. PubMed ID: 9150280
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP is an essential factor in immune responses.
Koh WS; Yang KH; Kaminski NE
Biochem Biophys Res Commun; 1995 Jan; 206(2):703-9. PubMed ID: 7826390
[TBL] [Abstract][Full Text] [Related]
7. Functional characteristics of Peyer's patch lymphoid cells. II. Lipopolysaccharide is thymus dependent.
Kagnoff MF; Billings P; Cohn M
J Exp Med; 1974 Feb; 139(2):407-13. PubMed ID: 4589992
[TBL] [Abstract][Full Text] [Related]
8. Effects of delta 9-tetrahydrocannabinol on glucagon receptor coupling to adenylate cyclase in rat liver plasma membranes.
Hillard CJ; Bloom AS; Houslay MD
Biochem Pharmacol; 1986 Aug; 35(16):2797-803. PubMed ID: 3017362
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-stimulable adenylyl cyclase in rat liver. The impact of streptozotocin-induced diabetes mellitus.
Dighe RR; Rojas FJ; Birnbaumer L; Garber AJ
J Clin Invest; 1984 Apr; 73(4):1013-23. PubMed ID: 6323532
[TBL] [Abstract][Full Text] [Related]
10. Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.
Wheeler MB; Lu M; Dillon JS; Leng XH; Chen C; Boyd AE
Endocrinology; 1993 Jul; 133(1):57-62. PubMed ID: 8391428
[TBL] [Abstract][Full Text] [Related]
11. Functional expression of the P2Y14 receptor in murine T-lymphocytes.
Scrivens M; Dickenson JM
Br J Pharmacol; 2005 Oct; 146(3):435-44. PubMed ID: 15997228
[TBL] [Abstract][Full Text] [Related]
12. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
Moens K; Heimberg H; Flamez D; Huypens P; Quartier E; Ling Z; Pipeleers D; Gremlich S; Thorens B; Schuit F
Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid.
Herring AC; Koh WS; Kaminski NE
Biochem Pharmacol; 1998 Apr; 55(7):1013-23. PubMed ID: 9605425
[TBL] [Abstract][Full Text] [Related]
14. Co-transfection with protein kinase D confers phorbol-ester-mediated inhibition on glucagon-stimulated cAMP accumulation in COS cells transfected to overexpress glucagon receptors.
Tobias ES; Rozengurt E; Connell JM; Houslay MD
Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):545-51. PubMed ID: 9291130
[TBL] [Abstract][Full Text] [Related]
15. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
16. Anti-human RP105 sera induces lymphocyte proliferation.
Roshak AK; Anderson KM; Holmes SD; Jonak Z; Bolognese B; Terrett J; Marshall LA
J Leukoc Biol; 1999 Jan; 65(1):43-9. PubMed ID: 9886245
[TBL] [Abstract][Full Text] [Related]
17. Hyperglucagonemia and altered responsiveness of hepatic adenylate cyclase-adenosine 3',5'-monophosphate system to hormonal stimulation during chronic ingestion of DL-ethionine.
Craven PA; Derubertis FR
Biochim Biophys Acta; 1977 Apr; 497(2):415-27. PubMed ID: 192313
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate-cyclase-activating polypeptide expression in the immune system.
Abad C; Martinez C; Leceta J; Juarranz MG; Delgado M; Gomariz RP
Neuroimmunomodulation; 2002-2003; 10(3):177-86. PubMed ID: 12481158
[TBL] [Abstract][Full Text] [Related]
19. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes.
Lee M; Yang KH; Kaminski NE
J Pharmacol Exp Ther; 1995 Nov; 275(2):529-36. PubMed ID: 7473135
[TBL] [Abstract][Full Text] [Related]
20. Glucagon stimulates adenylate cyclase through GR2 glucagon receptors: a process which can be attenuated by glucagon stimulating inositol phospholipid metabolism through GR1 glucagon receptors.
Houslay MD; Wakelam MJ; Murphy GJ; Gawler DJ; Pyne NJ
Biochem Soc Trans; 1987 Feb; 15(1):21-4. PubMed ID: 3030839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
